BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
276 hedge funds and large institutions have $6.46B invested in Blueprint Medicines in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 73 increasing their positions, 104 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
30% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 104
57% less call options, than puts
Call options by funds: $24.7M | Put options by funds: $57.9M
Holders
276
Holding in Top 10
7
Calls
$24.7M
Puts
$57.9M
Top Buyers
| 1 | +$304M | |
| 2 | +$110M | |
| 3 | +$43.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$40.5M |
| 5 |
BlackRock
New York
|
+$30.2M |
Top Sellers
| 1 | -$183M | |
| 2 | -$130M | |
| 3 | -$61.6M | |
| 4 |
DM
Deerfield Management
New York
|
-$37.6M |
| 5 |
Holocene Advisors
New York
|
-$32.4M |